Pediatrics

Pharmacy and Therapeutics committees around the country are taking a second look at what they're using for pediatric rehydration and how much they're willing to pay.

The American Heart Association issues new recommendations for treatment of pediatric stroke.

It has been 22 years since the Food and Drug Administration approved a new prescription drug treatment for head lice, but now several new remedies are on the horizon.

National Lipid Association issued a statement regarding new cholesterol guidelines for children.

WellPoint announced that effective immediately it will cover the Rotarix vaccine.

A pharmacist has written a book for moms who are struggling with colicky babies.

Boehringer Ingelheim's Aptivus can now be used to treat HIV-infected pediatric patients.

Doing an ECG first before kids get ADHD drugs is the preferred course of treatment, say AAP and AHA.

Eli Lilly's ADHD drug Strattera is now indicated for long-term use.

Wal-Mart and Playtex announce they are removing baby bottles containing bisphenol A (BPA) from store shelves.

The Joint Commission has issued some specific recommendations to hospitals in an effort to protect kids from drug errors.

The recent FDA voluntary withdrawal of cough and cold OTCs for infants has created a void that pharmacists should fill with patient counseling.

Results of a 16-week trial of insulin aspart

Bristol-Myers Squibb granted approval for arthritis biologic Orencia.

GlaxoSmithKline's vaccine, Rotarix, receives approval for use in children.

The FDA is undertaking a study of Merck?s Singulair to see if it is associated with a higher rate of suicide.

Mifamurtide available through compassionate access study

Study shows most adults use non-prescription medications for themselves and their children

Daptacel vaccine gets approved for fifth dose of DTaP

Health Resources & Services Administration launches poison help campaign

FDA issues warning on Tussionex use

National Autism Association holds press conference on mercury-containing vaccines and examine immunization schedule for risk.

Adalimumab approved for polyarticular juvenile idiopathic arthritis.

A nonprofit group concerned over short stature in kids opposes legislation now under consideration in Congress that would move human growth hormone into Schedule III of the Controlled Substances Act.

Aripiprazole approved for new indication.

Esomeprazole approved for children.

The Centers for Disease Control & Prevention recommends influenza vaccine for all children six months to 18 years old.

Novartis has received final approval for its combination product, Exforge, used to treat hypertension.

America?s pharmaceutical research companies, YMCA of the USA, and Easter Seals have joined forces to help uninsured children access health care.

According to a recent statement released by the American Academy of Pediatrics (AAP), the low reimbursement rates from insurance companies to providers for the cost of providing vaccines to children is a risk to their health.